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Svenningsen P, Uhrenholt TR, Palarasah Y, Skjødt K, Jensen
BL, Skøtt O. Prostasin-dependent activation of epithelial Na chan-
nels by low plasmin concentrations. Am J Physiol Regul Integr Comp
Physiol 297: R1733–R1741, 2009. First published September 30,
2009; doi:10.1152/ajpregu.00321.2009.—Several pathophysiological
conditions, including nephrotic syndrome, are characterized by in-
creased renal activity of the epithelial Na channel (ENaC). We
recently identified plasmin in nephrotic urine as a stimulator of ENaC
activity and undertook this study to investigate the mechanism by
which plasmin stimulates ENaC activity. Cy3-labeled plasmin was
found to bind to the surface of the mouse cortical collecting duct cell
line, M-1. Binding depended on a glycosylphosphatidylinositol (GPI)-
anchored protein. Biotin-label transfer showed that plasmin interacted
with the GPI-anchored protein prostasin on M-1 cells and that plasmin
cleaved prostasin. Prostasin activates ENaC by cleavage of the -sub-
unit, which releases an inhibitory peptide from the extracellular
domain. Removal of GPI-anchored proteins from the M-1 cells with
phosphatidylinositol-specific phospholipase C (PI-PLC) inhibited
plasmin-stimulated ENaC current in monolayers of M-1 cells at low
plasmin concentration (1–4 g/ml). At a high plasmin concentration
of 30 g/ml, there was no difference between cell layers treated with
or without PI-PLC. Knockdown of prostasin attenuated binding of
plasmin to M1 cells and blocked plasmin-stimulated ENaC current in
single M-1 cells, as measured by whole-cell patch clamp. In M-1 cells
expressing heterologous FLAG-tagged prostasin, ENaC and prosta-
sin were colocalized. A monoclonal antibody directed against the
inhibitory peptide of ENaC produced specific immunofluorescence
labeling of M-1 cells. Pretreatment with plasmin abolished labeling of
M-1 cells in a prostasin-dependent way. We conclude that, at low
concentrations, plasmin interacts with GPI-anchored prostasin, which
leads to cleavage of the -subunit and activation of ENaC, while at
higher concentrations, plasmin directly activates ENaC.
serine protease; sodium retention; kidney; M-1 cells; nephrotic syn-
drome
IN THE ALDOSTERONE-RESPONSIVE epithelial cells of kidney, the
epithelial sodium channel (ENaC) establishes the rate-limiting
step in transepithelial sodium transport, which is of critical
importance in the control of sodium balance, blood volume,
and blood pressure (45). The channel is composed of three
homologous subunits , , , (8), and each subunit has intra-
cellular N- and C-termini, two transmembrane domains, and a
large extracellular domain (18). The activity of ENaC is
regulated by hormones, e.g., aldosterone (2, 28, 30) and vaso-
pressin (13), and local factors, e.g., sodium concentration, pH,
and intracellular Ca2 (34). Moreover, within the last decade
serine proteases have also been shown to activate ENaC (42).
Serine proteases comprise a large family of proteolytic en-
zymes that are involved in a plethora of physiological and
pathophysiological functions, ranging from digestive proteases
that break down food proteins to proteases that recognize
specific cleavage sites (20). The exact mechanism by which
serine protease activates ENaC is still not resolved (37);
however, cleavage of the extracellular domain of the  and 
subunit seems to be a critical step in the proteolytic activation
of ENaC (24, 36). The cleavages of the extracellular domain
may lead to release of an inhibitory peptide and an increase in
the open-probability (5, 24). A fraction of the ENaC subunits
are cleaved within the biosynthesis pathway by the intracellular
protease furin (22, 23), giving rise to both noncleaved and
cleaved ENaC channels in the plasma membrane (23). Thus, at
the plasma membrane, a pool of noncleaved channels are
present, which can be activated by extracellular serine pro-
teases (1, 6, 7, 11, 42, 43). Several extracellular serine pro-
teases have been shown to activate ENaC in vitro through
cleavage of the  subunit, including channel activating pro-
tease 1 (CAP1/prostasin) (42), trypsin (42), chymotrypsin (11),
neutrophil elastase (6), and plasmin (35, 41) with prostasin as
the relevant candidate under physiological conditions (46).
Moreover, proteolytic ENaC activation may be a means of
regulating sodium reabsorption in kidney in vivo, since rats fed
a 1% sodium diet express both full-length and cleaved ENaC
at the plasma membrane, while Na-depleted or aldosterone-
treated rats mainly express the cleaved subunit (16).
We recently identified the serine protease plasmin as an
ENaC activator in urine from rats and humans with nephrotic
syndrome (41). Plasmin-stimulated ENaC activity could con-
tribute to the observed renin-angiotensin-aldosterone indepen-
dent primary sodium retention characteristic for the disease.
Plasmin was shown to stimulate ENaC activity in expression
systems and in collecting duct cells, as well as to cleave
purified -subunit (35, 41), leading to the release of an inhib-
itory peptide from the extracellular domain (41). Thus, this
study was undertaken to investigate potential interaction tar-
gets and mechanisms by which plasmin stimulates ENaC
activity in the collecting duct cell line M-1.
MATERIALS AND METHODS
Cell culture. M-1 cells were obtained from American Type Culture
Collection (Boras, Sweden) and grown in 25-cm2 flasks (Nunc,
Roskilde, Denmark) until confluence. The medium was DMEM:F12
(Life Technologies, Tåstrup, Denmark) supplemented with 5% FCS
(Life Technologies) and 5 M dexamethasone (Sigma, Broendby,
Denmark), and cells were kept at 37°C in 5% CO2.
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Biotin-label transfer experiment. Interaction partners of plasmin
were identified using ProFound Sulfo-SBED Biotin Label Transfer kit
(Pierce, Herlev, Denmark), as described by the manufacturer. Briefly,
plasmin was labeled with the biotinylated cross-linker sulfo-SBED.
Labeled plasmin was added to confluent M-1 cells grown in six-well
plates (Nunc) and incubated for 5 min at 37°C in 5% CO2. The
cross-linker was activated by UV-illumination for 15 min with cells
incubated on ice. Cells were lysed and biotinylated proteins were
precipitated with streptavidin-agarose. The pelleted proteins were
reduced and analyzed by immunoblotting.
siRNA-mediated knockdown. M-1 cells were transfected with
siRNA using DharmaFECT1 (Dharmacon, Herlev, Denmark), as
previously described (41). Prostasin was knocked down using 50 nM
ON-TARGET plus PRSS8 siRNA (cat. no. L-053718-01, Dharma-
con). For negative control, cells were transfected with Silencer Neg-
ative Control (cat. no. AM4611, Ambion, Naerum, Denmark).
PI-PLC was purchased from Invitrogen and used at a concentration
of 0.1 U/ml for at least 60 min prior to experiments. Recombinant
GST-tagged prostasin was purchased from Abnova (Taiwan), and
prostasin cleavages were assayed as described previously (32).
Reverse transcriptase-quantitative PCR. RNA was extracted from
M-1 cells in accordance with the manufacturer’s instructions (Qiagen
Mini Kit, Qiagen, Ballerup, Denmark) and reverse transcribed using
iScript cDNA synthesis kit (Bio-Rad, Copenhagen, Denmark). Pros-
tasin cDNA levels were measured using mouse prostasin primers.
Prostasin cDNA levels were normalized to 18S cDNA. All reactions
were run with IQ SYBR Green Supermix (Bio-Rad) on an Mx3000P
(Stratagene, La Jolla, CA) thermocycler.
Urine from rats with puromycin aminonucleoside-induced ne-
phrotic syndrome. Puromycin aminonucleoside (PAN) nephrosis in
rats was induced, and urine was collected, as previously described (3,
41). The experiments were approved by the Danish Animal Experi-
ments Inspectorate under the Department of Justice (171001-096).
Whole-cell patch clamp of single M-1 cells. Whole-cell patch
clamp was carried out as previously described (41). Briefly, M-1 cells
were seeded onto coverslips and incubated at 37°C in 5% CO2.
Patch-clamp experiments were conducted on single M-1 cells 24–48
h after seeding the cells. Current was monitored by the response to a
voltage step to 150 mV for 200 ms from a holding potential of 60
mV, which was repeated every second. The effect of rat plasmin (10
g/ml, Innovative Research, Novi, MI) was tested by dissolving in
bath solution and applying the sample by a pipette upstream of the
single M-1 cell with the solution containing plasmin.
Ussing chamber experiments. M-1 cells were grown on 1.12-cm2
filter supports (Corning, Brondby, Denmark) for 10–14 days and
mounted in a Ussing chamber (Physiologic Instruments, San Diego,
CA), bathed in saline solution containing: [in mmol/l: 116 NaCl, 24
NaHCO3, 4 KCl, 1 MgCl2, 1 CaCl2, 5 glucose], as described previ-
ously (41). The bath solution was kept at 37°C and continuously
bubbled with 5% CO2 in air to keep pH at 7.4 and assure stirring. To
minimize ENaC activation by endogenous proteases, the confluent
M-1 cells grown on filters were preincubated overnight with the furin
inhibitor dec-RVKR-cmk (decanoyl-Arg-Val-Lys-Arg-chloromethyl
ketone from BioMol/SMS-gruppen, Rungsted Kyst, Denmark) before
experiments. The effect of the different plasmin concentrations was
tested by monitoring the current induced by addition to the apical bath
of plasmin. Subsequently, trypsin (100 g/ml; Sigma) was added to
measure the maximal serine protease activatable ENaC activity. To
assess the involvement of glucosylphosphatidylinositol (GPI)-an-
chored proteins, monolayers were treated with or without 0.1 U/ml
PI-PLC (Invitrogen, Tåstrup, Denmark) for at least 1 h before exper-
iments. The amiloride-sensitive current was determined by adding
amiloride at a final concentration of 100 M to the apical bath at the
end of the experiment.
Laser-scanning confocal microscopy with plasmin-Cy3. The
fluorophore Cy3 (Amersham Biosciences, Hillerod, Denmark) was
coupled to rat plasmin (Innovative Research) according to the man-
ufacturer’s protocol. For imaging plasmin-Cy3 dynamics, plasmin-
Cy3 in DMEM:F12 (Invitrogen) was superfused to bind on M-1 cell
surface. Confocal laser-scanning fluorescence microscopy (Olympus
FV1000, Hamburg, Germany) was performed using a20 (numerical
aperture, 0.5) Olympus water immersion objective. The scanning area
was set to 512  512 pixels with and without internal zoom.
Full-frame imaging was performed at 1 Hz using excitation from a
laser at 559 nm with fluorescence monitored through a 570–670 nm
bandpass [Acousto-optic tunable filter (AOTF)]. Laser power was
adjusted (transmissivity 8%; photomultiplier tube voltage 450–550 V)
to obtain images with a mean intensity of 150 arbitrary intensity units
(range 100–4,095). This ensured fluorescence acquisition over the
full dynamic range of Plasmin-Cy3 without pixel saturation or exces-
sive photobleaching.
Generation and purification of monoclonal antibodies. To test the
cleavage of the ENaC subunit, we developed a monoclonal antibody
against the inhibitory peptide from the human ENaC subunit
(Acc. Num: NM_001039) corresponding to amino acid residue
139 –160. The peptide [EAESWNSVSEGKQPRFSHRIPLC] was
synthesized (EzBiolab, Carmel, IN) with an extra C-terminal
cysteine to facilitate conjugation to tuberculin-purified protein de-
rivative. BALB/cNMRI mice were immunized subcutaneously three
times with 25 g the peptide adsorbed to Al(OH)3, mixed in 1:1 ratio
with Freunds incomplete adjuvant. Four days prior to the fusion, the
mice received an intravenous injection with 25 g antigen adminis-
tered with adrenalin. The fusion and selection were done essentially as
described by Ko¨hler and Milstein (26). The SP2/0-AG14 myeloma
cell line was used as a fusion partner. Positive clones were selected by
differential screening against the peptide in ELISA. Cloning was
performed by limited dilution. Single clones were grown in culture
flasks in RPMI10% FCS, and mAbs were purified from culture
supernatant by protein A affinity chromatography using the äkta
FPLC system, according to the manufacturer’s instructions (Amer-
sham Pharmacia, Uppsala, Sweden).
Immunocytofluorescence. To test whether prostasin and ENaC are
colocalized, M-1 cells were grown on coverslips and transfected with
a plasmid expressing C-terminal FLAG-tagged human prostasin (Ori-
gene, Rockville, MD) using Lipofectamine LTX (Invitrogen), accord-
ing to the manufacturer’s instructions. Twenty-four hours after trans-
fection, the cells were fixed in 4% formaldehyde/PBS, washed with
PBS-Tween (PBST), and incubated with antibodies against the mouse
FLAG-tag (Sigma) and rabbit polyclonal ENaC antibody (Sigma)
for 1 h at room temperature. We used the Duolink proximity ligation
assay (Olink Bioscience, Uppsala, Sweden), according to the manu-
facturer’s instructions to test if prostasin and ENaC is colocalized.
To visualize punctate signals, intensity was enhanced post hoc (Fig.
4A) using Adobe Photoshop CS4. Furthermore, we tested the colo-
calization using standard immunofluorescence, where the primary
antibodies were detected using AlexaFluor568 goat anti-mouse (1:
200, Invitrogen) and AlexaFluor488 goat anti-rabbit (1:200, Invitro-
gen) for 1 h at room temperature. To test whether plasmin stimulation
leads to cleavage and release of the inhibitory peptide, M-1 cells
grown on coverslips were incubated with plasmin for 5 min at room
temperature in HBSS, briefly washed, and fixed for 10 min in 4%
formaldehyde in PBS. Coverslips were then washed in PBST and then
incubated with the ENaC inhibitory peptide-specific monoclonal
antibody and rabbit polyclonal ENaC antibody (Sigma) for 1 h at
room temperature. After incubation, the coverslips were washed in
PBST, and nucleic acid was visualized using DAPI (Invitrogen).
Actin was stained using Atto488-phalloidin (Sigma). Images were
acquired as stacks of images with confocal laser-scanning microscopy
(Olympus FV1000) using a 20 (numerical aperture, 0.5) Olympus
water immersion objective. The scanning area was set to 800  800
or 1,024  1,024 pixels with and without internal zoom. DAPI,
AlexaFluor488, and AlexaFluor568 were sequentially excited using
405-nm, 488-nm, and 559-nm lasers, respectively, and fluorescence
was monitored through appropriate filter settings (AOTF). The fluo-
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rescence signal from the monoclonal antibody was enhanced post hoc
using Adobe Photoshop CS4. Colocalization was calculated using the
Pearson-Spearman correlation colocalization plug-in (15) (http://www.
cpib.ac.uk/afrench/coloc.html) for Image J (version 1.40g, http://
rsb.info.nih.gov/ij/). The images are shown as maximum intensity
projections of stacks of 12–15 images.
Immunoblotting. M-1 cells were lysed in ice-cold Tris-EDTA
buffer [0.1 M Tris, 10 mM EDTA, 1 mM DTT, 1% Triton X-100, pH
7.2] containing Complete protease inhibitor (Roche, Hvidovre, Den-
mark), and 10 reducing agent (Invitrogen) and 4 LDS sample
buffer (Invitrogen) was added. After boiling, the samples were sub-
jected to SDS-PAGE (Bio-Rad) and subsequently transferred to a
PVDF membrane (Immobilon-P, Millipore, Copenhagen, Denmark).
Blots were probed with monoclonal mouse anti-human prostasin (BD
Biosciences, Brondby Denmark) or polyclonal rabbit anti-actin (Ab-
cam, Cambridge, MA). Primary antibodies were detected with HRP-
coupled antibodies (Dako, Glostrup, Denmark) and enhanced chemi-
luminescence system (Amersham Biosciences).
Statistics. Results are presented as mean	 SE, and n is the number
of observations. SigmaPlot 9.0 (Systat Software, Chicago, IL) was
used for data analysis and data fitting. P 
 0.05 was considered
significant.
RESULTS
Plasmin interacts with prostasin. Cy3-labeled plasmin was
employed to elucidate whether plasmin binds to the cell surface
of the mouse renal cortical collecting duct cell line, M-1. In
superfusion experiments, 10 g/ml of Cy3-labeled plasmin
rapidly binds to the surface of live M-1 cells (see Fig. 1A and
Supplemental Video 1 in the online version of this article). To
identify the interaction partner of plasmin, biotin-label transfer
was used. After stimulation of M-1 cells with plasmin conju-
gated to a biotin-labeled cross-linker, biotin-tagged proteins
were precipitated using streptavidin and subjected to immuno-
blotting. Fig. 1B shows an immunoblot against biotinylated
proteins after biotin transfer. In the lanes using plasmin con-
centrations of 20–40 g, a significant band at 40 kDa was
detected. When the ENaC-activating serine protease trypsin
Fig. 1. Plasmin interacts with prostasin.
A: fluorescence traces were obtained in M-1
cells that were superfused with Cy3-coupled
plasmin (10 g/ml), and emitted fluorescence
was recorded by confocal microscopy. After
the addition of Cy3-coupled plasmin, the fluo-
rescence intensity increases rapidly, indicating
that plasmin binds M-1 cells. Solid and open
circles represent cell numbers 1 and 2, respec-
tively, which can be seen live in Supplemental
Video 1 in the online version of this article.
B, top: immunoblot shows precipitate from
streptavidin precipitation of M-1 cells after
crosslinking with plasmin (10–40 g/ml) and
trypsin (10–40 g/ml). It can be seen that
plasmin interacts with a40-kDa protein, and
trypsin interacts with several molecules be-
tween 50 and 90 kDa. Bottom: Western blot
shows that the 40-kDa plasmin-interacting
protein reacts with a specific antibody directed
against prostasin (n  3). C: monolayers of
M-1 cells were treated with PI-PLC (0.1 U/ml)
added to the medium. After incubation, cell-
conditioned medium and cell lysate were har-
vested and used for Western blotting for pros-
tasin. PI-PLC treatment reduces the prostasin
level in the cell lysate and increases the pros-
tasin level in the culture medium. D: fluores-
cence traces from M-1 cells that preincubated
with PI-PLC before treatment with Cy3-la-
beled plasmin. The traces show that PI-PLC
treatment of the cells leads to a reduced fluo-
rescence signal, i.e., less binding of plasmin,
compared with control cells after superfusion
with Cy3-plasmin (1 g/ml, n  30 cells).
E: bar graph depicts the average emitted fluo-
rescence 	 SE from M-1 cells treated with or
without PI-PLC and subsequently superfused
with Cy3-plasmin (n  3). *P 
 0.05.
F: immunoblot of GST-tagged prostasin
probed with a specific prostasin antibody.
GST-tagged prostasin was incubated with or
without plasmin. Incubation with plasmin
leads to cleavage of GST-tagged prostasin
in vitro.
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was used for biotin-label transfer, several bands ranging from
50 to 90 kDa appeared on the blots, but the band at 40 kDa was
not detectable. Further immunoblot analysis identified the
40-kDa band as prostasin (Fig. 1B), which is a GPI-anchored
ENaC activating serine protease (1, 9, 42). To assess the
importance of the GPI anchor for the binding of plasmin to
M-1 cell surfaces, cells were pretreated with phosphatidylinos-
itol-specific phospholipase C (PI-PLC), which cleaves GPI
anchors. After incubation with PI-PLC, the level of prostasin in
the cell lysate was reduced, whereas the prostasin level in the
culture medium increased (Fig. 1C). This indicates that pros-
tasin is mainly anchored to the cell surface via a GPI-anchor in
M-1 cells. The PI-PLC-treated cells showed a reduced binding
of 1 g/ml Cy3-labeled plasmin compared with control cells,
indicating that a GPI-anchored protein is involved in the
binding (Fig. 1, D and E). Prostasin is synthesized as an inactive
zymogen that is activated by a single endoproteolytic cleavage.
The activation of prostasin has been shown to occur at the plasma
membrane (32). Using recombinant prostasin with a C-terminal
GST-tag, we tested whether plasmin could cleave prostasin. After
prostasin incubated with plasmin, two bands appeared, with the
estimated size of full-length prostasin and prostasin cleaved at the
activation site (Fig. 1F). Next, site-specific siRNA-mediated
knockdown of prostasin expression in M-1 cells was used to
examine binding of labeled plasmin. In a concentration-response
experiment, transfection of M-1 cells with prostasin siRNA led to
a concentration-dependent decrease in prostasin mRNA level
(Fig. 2A). A maximal prostasin mRNA knockdown was achieved
at a siRNA concentration of 50 nM. This concentration also led to
knockdown of prostasin at the protein level (Fig. 2A, right) and
was used in subsequent experiments. Prostasin knockdown sig-
nificantly attenuated binding of Cy3-labeled plasmin to M-1 cells
(Fig. 2B). Thus, the data suggest that plasmin interacts with and
activates prostasin on the cell surface of M-1 cells.
Involvement of prostasin in plasmin-stimulated ENaC activ-
ity. We next investigated whether prostasin was functionally
involved in plasmin-stimulated ENaC activity. To test whether
a GPI-anchored protein is involved in plasmin-stimulated
ENaC activity, monolayers of M-1 cells were treated with or
without PI-PLC before measuring the short-circuit currents in
response to different plasmin concentrations. The PI-PLC-
treated monolayers showed a reduced plasmin-stimulated cur-
rent compared with control monolayers at plasmin concentra-
tions of 1.3 to 3.90 g/ml (Fig. 3A). However, there was no
difference between monolayers treated with or without PI-PLC
when using the high plasmin concentration (30 g/ml) (Fig.
3A). Moreover, no differences in baseline, trypsin, and amilo-
ride-insensitive short-circuit currents in monolayers treated
with or without PI-PLC were detected (Fig. 3B). These data
indicate that at least in the range of plasmin concentrations
between 1–4 g/ml, a GPI-anchored protein is necessary for
the plasmin-stimulated ENaC activity, while at higher concen-
trations a direct interaction with ENaC is more likely.
The functional significance of prostasin knockdown was
tested using the whole-cell configuration of the patch-clamp
technique. Single M-1 cells transfected with control siRNA (50
nmol/l) showed a significant increase in whole-cell current
after stimulation with plasmin (10 g/ml) or nephrotic urine
(Fig. 3, C and D), which we previously have shown to be
mediated by ENaC (41). However, siRNA-mediated knock-
down of prostasin blocked the ability of plasmin (10 g/ml)
and nephrotic rat urine to stimulate ENaC current in M-1 cells
(Fig. 3, C and D). This suggests that prostasin is involved in
plasmin-stimulated ENaC activity.
Prostasin and ENaC are colocalized in M-1 cells. Attempts
to detect endogenous prostasin using immunofluorescence
were unsuccessful, and therefore, we expressed human prosta-
sin with a C-terminal FLAG-tag in M-1 cells. We found that
Fig. 2. A: bar graph shows the effect of transfection
of M-1 cells with increasing concentrations of spe-
cific siRNAs directed against prostasin on the abun-
dance of prostasin mRNA (means 	 SE). Cells
were transfected with prostasin siRNAs, and pros-
tasin mRNA levels were assessed the following day
using quantitative RT-PCR (n  4). Prostasin pro-
tein abundance was determined by Western blot
analysis of M-1 cell protein homogenates 2 days
after siRNA transfection (50 nmol/l). Right: result
of blots for prostasin (top) and -actin (lower).
B: bar graph shows the effect of siRNA-mediated
(50 nmol/l) knockdown of prostasin on binding of
Cy3-labeled plasmin to M-1 cells, as determined by
confocal microscopy (n 6). F: cell fluorescence at
the end of the experiment; F0: fluorescence at the
start of experiment.
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immunofluorescence images of M-1 cells transfected with
FLAG-tagged prostasin showed colocalization of prostasin and
ENaC (Pearson coefficient 0.74 and Spearman coefficient
0.59), in contrast to mock-transfected cells in which no pros-
tasin labeling was detected (see Supplemental Fig. 1 in the
online version of this article). We used the Duolink in situ
proximity ligation assay (40) to corroborate the colocalization
of prostasin and ENaC. Using primary antibodies from two
different species, e.g., rabbit anti-ENaC directed against the
nonprocessed cytoplasmic part and mouse anti-FLAG, this
assay is capable of reporting whether proteins are in close
proximity (
40 nm) of each other, which is indicated by bright
red fluorescent spots. In a subset of M-1 cells expressing the
FLAG-tagged prostasin, a punctuated fluorescent signal was
observed that indicates that prostasin and ENaC are separated
by less than 40 nm (Fig. 4A). Because cells were permeabil-
ized, it is not possible to determine whether colocalization is
confined to the cell surface. Cells not expressing the FLAG-
tagged prostasin and omission of the ENaC antibody abol-
ished this labeling pattern (not shown). Thus, these data indi-
cate that prostasin and ENaC are colocalized in M-1 cells.
Plasmin induces prostasin-dependent release of ENaC inhib-
itory peptide. We (41) and others (35) have previously shown that
plasmin induces cleavage of ENaC. To test whether prostasin is
involved in the plasmin-induced cleavage of ENaC, we gener-
ated a monoclonal antibody directed against the N-terminal part of
the proposed inhibitory peptide. The antibody yielded no labeling
of mock-transfected human embryonic kidney cells but produced
marked labeling af M-1 cells transfected with ENaC expression
vector (see Supplemental Fig. 2 in the online version of this
article). Immunoblotting showed that the antibody yielded two
prominent bands in native M1 plasma membrane fractions. Two
products exhibited molecular size around 100 kDa and one was
below 75 kDa (Supplemental Fig. 2). Using confocal laser-
scanning microscopy, we found that the antibody yielded specific
labeling that was associated with M-1 cells and that preabsorption
of the antibody with 10 g/ml of the immunogenic peptide
abolished the labeling (Fig. 4B). Pretreatment of the cells with 10
g/ml plasmin for 5 min abolished labeling, which indicates that
plasmin releases the ENaC inhibitory peptide (Fig. 4B). Com-
pared with cells transfected with negative control siRNA, cells
transfected with prostasin siRNA displayed a stronger immuno-
Fig. 3. Effect of GPI-anchored prostasin on plasmin-stimulated ENaC currents in M-1 cells. A: average ratio between plasmin-activated (Plasmin) and
trypsin-activated (Trypsin) short-circuit currents from M-1 cell monolayers grown on permeable filters and mounted in Ussing chambers. First, M-1 cells were
treated with or without phospholipase C (PI-PLC) to disrupt GPI anchors. Next, the short-circuit current response to different plasmin concentrations was
evaluated (Plasmin). Subsequently, trypsin was added, and the trypsin-induced current (Trypsin) was used to normalize the plasmin-induced current
(Plasmin/Trypsin). Plasmin-evoked currents were larger in M-1 cells not pretreated with PI-PLC in a low concentration range of plasmin, whereas at higher
concentrations of plasmin, the PI-PLC treatment did not attenuate the current. This suggests involvement of a GPI-anchored protein in the response to plasmin
at concentrations below 10 g/ml. *P 
 0.05, **P 
 0.01. B: short-circuit current from M-1 cell monolayers mounted in Ussing chambers and pretreated with
PI-PLC or vehicle. Trypsin enhanced significantly short-circuit current independent of PI-PLC pretreatment, and this was abolished by the addition of amiloride
(n  5). C: original current traces in response to a step depolarization obtained in single M-1 cells by patch-clamp recordings. M-1 cells were mock transfected
(control siRNA) or transfected with prostasin siRNA 2 days before the experiments. Gray traces are from cells before superfusion with pure plasmin (10 g/ml)
or urine from rats with proteinuria (PAN nephrosis), and black traces are from same cells after superfusion with plasmin or rat urine. D: bar graph shows the
average changes in current obtained in patch-clamp experiments with single M-1 cells in response to plasmin (10 g/ml) and nephrotic urine. Pretreatment with
prostasin siRNAs significantly attenuated plasmin- and nephrotic urine-evoked currents in M-1 cells. (n  4), *P 
 0.05.
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fluorescence labeling with the antibody after pretreatment with
5–10 g/ml plasmin (Fig. 4C). However, there was no difference
detected in the labeling pattern between M-1 cells transfected with
negative control and prostasin siRNA after pretreatment with 30
g/ml plasmin siRNA (Fig. 4C). These data suggest that at low
plasmin concentration, prostasin is involved in the cleavage of the
ENaC subunit.
DISCUSSION
We have recently shown that plasminogen is filtered across
the glomerular barrier in a rat model of nephrotic syndrome
and subsequently activated to plasmin by urokinase-type plas-
minogen activator in the renal tubular system (41). Pure plas-
min and nephrotic urine, which contains active plasmin, acti-
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vate ENaC by proteolytic modification of the  subunit (35,
41). The present study was undertaken to investigate the
mechanism by which plasmin stimulates ENaC activity. Our
data show that pure plasmin binds to GPI-anchored prostasin
on the surface of M-1 cells and that plasmin treatment of
tagged prostasin results in the appearance of a cleavage prod-
uct, which is compatible with proteolytic modification. Pros-
tasin subsequently cleaves the  subunit of ENaC, leading to
the release of an inhibitory peptide from the extracellular
domain and activation of the channel. The effect of plasmin
was concentration dependent, and in the high range of tested
concentrations, plasmin activated ENaC directly.
It is well known that cascades of sequential activation of
serine proteases drive processes, such as blood coagulation,
complement fixation, and fibrinolysis (20). Prostasin is a down-
stream target in a proteolytic cascade that involves matriptase
in a process regulating terminal epidermal differentiation (27,
32). However, the finding that plasmin-stimulated ENaC ac-
tivity involves a serine protease cascade with prostasin is
novel. Our data cannot rule out that a serial proteolytic action
of prostasin and plasmin on ENaC is responsible for the
observed effect. However, ENaC is fully activated by furin-
and prostasin-dependent release of the inhibitory peptide from
the  subunit (4), and the proposed cleavage sites for prostasin
and plasmin (at high concentrations) are located adjacent to
each other (35). Thus, a mechanism involving sequential pros-
tasin- and plasmin-dependent ENaC cleavage seems less
likely. Because prostasin is expressed in collecting ducts
in vivo (46), this observation may be relevant to understand the
pathophysiological ENaC-dependent NaCl retention associated
with proteinuric diseases such as nephrotic syndrome (41) and
anti-Thy1 glomerulonephritis (17). Proteolytic processing of
ENaC blunts Na self-inhibition (10, 39) by releasing the
inhibitory peptide form the -subunit. The inhibitory peptide is
flanked by cleavage sites for furin, on one side, and prostasin
and plasmin (at a high concentration) on the other.
The set of data indicates that plasmin interacts with GPI-
anchored prostasin. In agreement with previous observations
(9), we found that the major pool of endogenously expressed
prostasin in M-1 cells was GPI-anchored. In the low range of
the tested plasmin concentrations (below 10 g/ml), we found
that intact GPI-anchored proteins and prostasin expression
were necessary for stimulation of ENaC, whereas at higher
concentrations, the plasmin-stimulation was independent of
GPI-anchored proteins. GPI-anchored proteins are mainly lo-
cated in microdomains termed lipid rafts (38), which have also
been shown to contain endogenous ENaC (21). This is in
agreement with our finding that prostasin and ENaC are
colocalized. The anchoring of prostasin in lipid rafts appears to
be important for its ENaC-activating function, since mutation
of the GPI-anchored motif in prostasin leaves it unable to
activate ENaC (44). Thus, at low plasmin concentration, lipid
rafts could provide an environment, which favors the plasmin-
stimulated ENaC activity through prostasin. Passero et al. (35)
have observed an additional ENaC cleavage product when
using plasmin at a high concentration (27 g/ml), which could
be abolished by mutating a site (K194A) distal to the pros-
tasin cleavage site. This is in agreement with our data and
suggests that at high concentrations, plasmin interacts and
cleaves ENaC directly. Similar to this observation, trypsin-
stimulated ENaC activity was not dependent on prostasin. In
accord, trypsin interacted with several molecules in M-1 cells
larger than prostasin, with a size that ranged from 50 to 90 kDa.
The two prominent trypsin-interacting molecules of sizes
around 80 and 90 kDa might be speculated to be the  subunit
of ENaC (19). Although the present data show that prostasin is
involved in plasmin-stimulated ENaC activation, we cannot
rule out that there exist further intermediate steps between
prostasin and ENaC and other techniques with higher spatial
resolution, e.g., fluorescence resonance energy transfer, should
be used to resolve this issue.
Fig. 4. Stimulation of M-1 cells with plasmin leads to prostasin-dependent cleavage of ENaC. A: Duolink in situ proximity ligation assay was used to test the
hypothesis that prostasin and ENaC are closely adjacent in M-1 cells. The immunocytofluorescence labeling shows that prostasin and ENaC are separated by
less than 40 nm (bright red spots) in M-1 cells expressing FLAG-tagged prostasin. Cytoplasmic actin was visualized with phalloidin-Atto488 (green), and cell
nuclei were visualized with DAPI (blue). Right: magnification of the boxed area. Red signal intensity was increased post hoc. B: immunofluorescence labeling
of M-1 cells with a specific antibody directed against the inhibitory peptide segment of the ENaC extracellular domain (red fluorescence signal). Labeling is
associated with control M-1 cells (red). Nuclei are stained blue with DAPI. Labeling is abolished by preabsorption of the antibody with the immunogenic peptide
(middle) and prevented after pretreatment of M-1 cells with 10 g/ml plasmin for 5 min (right). Blue staining denotes DAPI staining. Green staining denotes
labeling of actin cytoskeleton with phalloidin-Atto488. Scale bar 10 m. C: immunofluorescence labeling of M-1 cells with specific antibodies directed against
the inhibitory peptide-segment within the extracellular domain of ENaC (red fluorescence) and a region of ENaC, which is not proteolytically modified (green
fluorescence). M-1 cells were pretreated with siRNA directed against prostasin (bottom) or negative control siRNA (top). Before immunofluorescensce labeling,
prostasin-siRNA-treated and control siRNA-treated cells incubated with increasing concentrations of plasmin. Plasmin concentration dependently prevented
labeling for the inhibitory ENaC-peptide in M-1 cells treated with control siRNA (top). In M-1 cells treated with siRNA directed against prostasin, plasmin
had a reduced ability to prevent labeling for the inhibitory ENaC-peptide (red signal), whereas labeling for a region of ENaC, which is not proteolytically
modified (green signal) was not altered (bottom). Blue staining of cell nuclei with DAPI. Green staining denotes cytoplasmic epitope of ENaC. Red denotes
inhibitory peptide of ENaC extracellular domain. Red signal intensity was amplified post hoc in this photo. Scale bar: 10 m.
Fig. 5. Proposed model for plasmin-stimulated ENaC activity. At low con-
centration, plasmin interacts with GPI-anchored prostasin at the cell surface,
which subsequently leads to cleavages of the  subunit of ENaC and release of
the inhibitory peptide. At high concentrations, plasmin-stimulated ENaC
activity does not appear to involve prostasin but occurs through direct cleavage
of the subunit.
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The (patho)physiological consequences of these findings
remain elusive at present. Recently, we have shown that
plasmin in nephrotic urine from humans and rats activates
ENaC (41). On the basis of a serine protease activity assay, we
have estimated a plasmin concentration of 10–15 g/ml in
urine from puromycin aminonucleoside-induced nephrotic
syndrome in rats at the peak of proteinuria (data not shown).
Thus, the prostasin-dependent step in plasmin-stimulated
ENaC activity would probably play a minor role in sodium
retention at the peak of proteinuria. However, human nephrotic
urine displayed a much lower serine protease activity com-
pared with rat urine from the PAN nephrotic model (41),
suggesting that ENaC activation and sodium retention in ne-
phrotic patients could be prostasin-dependent. Moreover, the
proteinuria in nephrotic patients is at the extreme of the
spectrum, and most clinical proteinuric conditions exhibit a
lower degree of proteinuria.
Recent data show that the  subunit of ENaC exists at the
cell surface with smaller molecular size than full-length sub-
units, depending on SGK1 and sodium status (14), such that
Na-depletion increases the cleaved form several times at the
membrane surface (16). A recent study showed that ENaC
subunit appears to be proteolytic processed in proteinuric
glomerulonephritis (17). Thus, proteolytic modification of
ENaC appears to occur under physiological and pathophysi-
ological conditions. The dominance of cleaved ENaC at the
cell surface in sodium-depleted states is consistent with the
observation that prostasin expression is stimulated by aldoste-
rone (31, 33). Intriguingly, camostat mesilate has been shown
to be an inhibitor of prostasin activity (12, 29) that reduced
blood pressure and renal injury in salt-sensitive rats (29). In
patients with advanced diabetic nephropathy camostat reduced
edema volume (25). Although indirect, these data are in accord
with a role of prostasin to promote sodium retention in vivo.
Perspectives and Significance
The present study provides evidence that plasmin-stimulated
ENaC activity depends on GPI-anchored prostasin at low
plasmin concentration, whereas the activation is prostasin in-
dependent at high plasmin concentrations (Fig. 5). The study
identifies prostasin as a potential drug target in diseases with
proteinuria and abnormal activation of ENaC.
Nephrotic syndrome is at one extreme of an array of proteinuric
conditions. Several human diseases, e.g., other primary kidney
disease, diabetes mellitus, hypertension, and preeclampsia are
characterized by microalbuminuria (or proteinuria) and sodium
retention. Thus, it is of interest to establish whether tubular
formation of prostasin-dependent plasmin-stimulated ENaC
activation may contribute to sodium retention in these condi-
tions.
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